X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.500
+0.170 (5.11%)
Mar 4, 2026, 4:00 PM EST - Market closed
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $306.03 million as of March 5, 2026. Its market cap has increased by 259.96% in one year.
Market Cap
306.03M
Enterprise Value
261.19M
1-Year Change
259.96%
Ranking
Category
Stock Price
$3.50
Market Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $306.03M, an increase of 200.70%. That is a compound annual growth rate of 17.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 306.03M | -12.50% |
| Dec 31, 2025 | 349.75M | 179.54% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XOMA Royalty | 309.70M |
| Puma Biotechnology | 298.64M |
| Adlai Nortye | 295.94M |
| Cellectis | 294.41M |
| Nautilus Biotechnology | 293.03M |
| Fennec Pharmaceuticals | 291.02M |
| AC Immune | 285.95M |
| Opus Genetics | 280.68M |